Switch to:

Sangamo Therapeutics Change In Payables And Accrued Expense

: $-1.1 Mil (TTM As of Sep. 2020)
View and export this data going back to 2000. Start your Free Trial

Sangamo Therapeutics's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2020 was $-0.2 Mil. It means Sangamo Therapeutics's Accounts Payable & Accrued Expense declined by $0.2 Mil from Jun. 2020 to Sep. 2020 .

Sangamo Therapeutics's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2019 was $-4.2 Mil. It means Sangamo Therapeutics's Accounts Payable & Accrued Expense declined by $4.2 Mil from Dec. 2018 to Dec. 2019 .


Sangamo Therapeutics Change In Payables And Accrued Expense Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Sangamo Therapeutics Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Change In Payables And Accrued Expense Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.76 -2.34 3.22 -6.37 -4.19

Sangamo Therapeutics Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Change In Payables And Accrued Expense Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.56 -2.44 0.35 1.21 -0.22

Sangamo Therapeutics Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2020 was -2.439 (Dec. 2019 ) + 0.345 (Mar. 2020 ) + 1.214 (Jun. 2020 ) + -0.223 (Sep. 2020 ) = $-1.1 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Sangamo Therapeutics Change In Payables And Accrued Expense Related Terms


Sangamo Therapeutics Change In Payables And Accrued Expense Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)